Rocuronium Bromide (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Rocuronium Bromide drug offered from Teva Parenteral Medicines, Inc.. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Rocuronium Bromide
SUBSTANCE NAME: ROCURONIUM BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-12-01
END MARKETING DATE: 0000-00-00


Rocuronium Bromide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRocuronium Bromide from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2008-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-2394_5f3aa05d-26c6-48fc-9a2c-dc0118d020a4
PRODUCT NDC: 0703-2394
APPLICATION NUMBER: ANDA078717

Other ROCURONIUM BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aurobindo Pharma LimitedRocuronium Bromide
AuroMedics Pharma LLCRocuronium Bromide
Cantrell Drug CompanyRocuronium Bromide
Fresenius Kabi USA, LLCRocuronium
Hospira, Inc.ROCURONIUM BROMIDE
Mylan Institutional LLCRocuronium Bromide
Organon USA Inc.Zemuron
Sagent Pharmaceuticalsrocuronium bromide
Sandoz IncRocuronium Bromide
Teva Parenteral Medicines, Inc.Rocuronium Bromide
The Medicines CompanyRocuronium
West-Ward Pharmaceuticals CorpRocuronium Bromide
X-GEN Pharmaceuticals, Inc.rocuronium bromide